|
Market Closed -
Xetra
11:36:33 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 136.90 EUR | +1.82% |
|
+1.41% | +11.66% |
| 09-29 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 09-23 | Bio-Techne Shareholders Approve Takeover by Merck KGaA | MT |
| Market Cap | 59.52B 66.99B 55.55B 50.63B 95.5B 6,440B 96.39B 672B 261B 3,292B 252B 246B 10,566B | P/E 2026 * |
23.2x | P/E 2027 * | 20.4x |
|---|---|---|---|---|---|
| Enterprise Value | 67.27B 75.71B 62.79B 57.23B 108B 7,279B 109B 760B 294B 3,721B 284B 278B 11,942B | EV / Sales 2026 * |
3.13x | EV / Sales 2027 * | 2.89x |
| Free-Float |
29.73% | Yield 2026 * |
1.72% | Yield 2027 * | 1.76% |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| MRK | Delayed | |
CBOE
| MRKd | Real-time | |
Tradegate
| MRK | Real-time | |
Boerse Muenchen
| MRK | Real-time | |
OTC Markets
| MKGA.F | Delayed | |
London S.E.
| 0O14 | Delayed | |
Deutsche Boerse AG
| MRK | Delayed | |
Börse Stuttgart
| MRK | Delayed | |
Borsa Italiana
| 1MRK | End-of-day quote | |
Swiss Exchange
| MER | Delayed | |
CBOE
| 0O14 | Real-time | |
Wiener Boerse
| MRCK | End-of-day quote |
Last Transcript: Merck KGaA
| 1 day | +1.82% | ||
| 1 week | +1.41% | ||
| Current month | -0.87% | ||
| 1 month | -0.69% | ||
| 3 months | -6.01% | ||
| 6 months | +24.68% | ||
| Current year | +11.66% |
| 1 week | 132.95 | 139.95 | |
| 1 month | 129.15 | 139.95 | |
| Current year | 100.7 | 148.8 | |
| 1 year | 100.7 | 148.8 | |
| 3 years | 100.7 | 177 | |
| 5 years | 100.7 | 231.5 | |
| 10 years | 74.54 | 231.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kai Beckmann
CEO | Chief Executive Officer | 61 | 2026-04-30 |
| Director of Finance/CFO | 56 | 2023-06-30 | |
Gangolf Schrimpf
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Christian Raabe
BRD | Director/Board Member | 62 | 2019-04-25 |
Dietmar Oeter
BRD | Director/Board Member | 60 | 2014-05-08 |
Alexander Putz
BRD | Director/Board Member | 50 | 2020-05-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/25/26 | Buy | Chief Executive Officer | 3,386 | 0.0026% | ||
| 3/25/26 | Buy | Chief Financial Officer | 4,563 | 0.0035% | ||
| 3/27/25 | Buy | 1,401 | 0.0011% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.82% | +1.41% | +13.28% | -11.22% | 66.99B | ||
| -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | ||
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | ||
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | ||
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | ||
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | ||
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | ||
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | ||
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | ||
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | ||
| Average | -0.50% | -2.91% | +24.79% | +51.89% | 376.42B | |
| Weighted average by Cap. | -0.56% | -3.24% | +28.79% | +69.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.48B 24.17B 20.05B 18.27B 34.46B 2,324B 34.78B 243B 94B 1,188B 90.76B 88.79B 3,813B | 22.64B 25.49B 21.13B 19.26B 36.33B 2,450B 36.67B 256B 99.11B 1,252B 95.69B 93.61B 4,020B |
| Net income | 2.55B 2.87B 2.38B 2.17B 4.1B 276B 4.14B 28.85B 11.18B 141B 10.79B 10.56B 453B | 2.85B 3.21B 2.66B 2.42B 4.57B 308B 4.61B 32.19B 12.47B 158B 12.04B 11.78B 506B |
| Net Debt | 7.75B 8.72B 7.23B 6.59B 12.44B 839B 12.55B 87.55B 33.92B 429B 32.75B 32.04B 1,376B | 5.83B 6.56B 5.44B 4.96B 9.35B 631B 9.44B 65.83B 25.51B 322B 24.63B 24.09B 1,035B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | €136.90 | +1.82% | 260,313 |
| 26-10-01 | €134.45 | -2.64% | 234,143 |
| 26-09-30 | €138.10 | +0.51% | 307,219 |
| 26-09-29 | €137.40 | -0.76% | 348,118 |
| 26-09-28 | €138.45 | +2.56% | 259,956 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRK Stock
Select your edition
All financial news and data tailored to specific country editions





















